That was alkon's point in the audio interview. He says you almost never see a drug show such a trend analysis. What he means is every data point for every patient is going on an uptrend of the 94% who were helped. When you look at things like that its not simply 15 out of 16 patients its 60 data points for the 15 responders. That's why the one stat sig number was so incredibly low.
News 
Market Data 
Discover 
